TR200001688T2 - TTS içeren bir antioksidant. - Google Patents

TTS içeren bir antioksidant.

Info

Publication number
TR200001688T2
TR200001688T2 TR2000/01688T TR200001688T TR200001688T2 TR 200001688 T2 TR200001688 T2 TR 200001688T2 TR 2000/01688 T TR2000/01688 T TR 2000/01688T TR 200001688 T TR200001688 T TR 200001688T TR 200001688 T2 TR200001688 T2 TR 200001688T2
Authority
TR
Turkey
Prior art keywords
antioxidant containing
ethyl
containing tts
tts
carbamate
Prior art date
Application number
TR2000/01688T
Other languages
English (en)
Inventor
Asmussen Bodo
Horstmann Michael
K�Pke Kai
Tiemessen Harry
Original Assignee
Novartis Ag
Lst Lohmann Therapie-Systeme Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200001688(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Lst Lohmann Therapie-Systeme Gmbh & Co. Kg filed Critical Novartis Ag
Publication of TR200001688T2 publication Critical patent/TR200001688T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Serbest baz veya asit eklenik tuz formundaki (S)-N-etil-3-(1-dimetilamino) etil)-N-metilfenil-karbamat ve bir anti-oksidanttan olusan farmasötik kompozisyon. Bahsedilen farmasötik kompozisyonlar; transdermal bir dagitim tertibatini kullanarak bir hastaya dagitilabilmektedir.
TR2000/01688T 1998-01-12 1999-01-08 TTS içeren bir antioksidant. TR200001688T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9800526.7A GB9800526D0 (en) 1998-01-12 1998-01-12 Organic compounds

Publications (1)

Publication Number Publication Date
TR200001688T2 true TR200001688T2 (tr) 2000-11-21

Family

ID=10825116

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2001/01021T TR200101021T2 (tr) 1998-01-12 1999-01-08 TTS içeren bir antioksidant
TR2000/01688T TR200001688T2 (tr) 1998-01-12 1999-01-08 TTS içeren bir antioksidant.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2001/01021T TR200101021T2 (tr) 1998-01-12 1999-01-08 TTS içeren bir antioksidant

Country Status (26)

Country Link
US (1) US6335031B1 (tr)
EP (1) EP1047409B1 (tr)
KR (1) KR100569051B1 (tr)
CN (1) CN1129427C (tr)
AT (1) ATE223711T1 (tr)
AU (1) AU745661B2 (tr)
BR (1) BR9906920A (tr)
CA (1) CA2315784C (tr)
CZ (1) CZ300598B6 (tr)
DE (1) DE69902875T2 (tr)
DK (1) DK1047409T3 (tr)
ES (1) ES2184408T3 (tr)
GB (1) GB9800526D0 (tr)
HK (1) HK1034036A1 (tr)
HU (1) HU227159B1 (tr)
ID (1) ID27503A (tr)
IL (1) IL137100A (tr)
MX (1) MXPA00006438A (tr)
NO (1) NO328390B1 (tr)
NZ (1) NZ505650A (tr)
PL (1) PL201328B1 (tr)
PT (1) PT1047409E (tr)
RU (1) RU2219926C2 (tr)
SK (1) SK284622B6 (tr)
TR (2) TR200101021T2 (tr)
WO (1) WO1999034782A1 (tr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ510683A (en) * 1998-10-01 2003-09-26 Novartis Ag Sustained release oral formulations of rivastigmine
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
EP1233763B1 (de) * 1999-11-29 2003-07-30 LTS Lohmann Therapie-Systeme AG Transdermale therapeutische systeme mit verbesserter stabilität und ein verfahren zu ihrer herstellung
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) * 2005-02-04 2006-08-11 Frederic Khodja Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
JP5295356B2 (ja) 2008-07-28 2013-09-18 武田薬品工業株式会社 医薬組成物
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
KR101674240B1 (ko) 2009-12-22 2016-11-08 아시노 아게 리바스티그민 또는 그의 유도체 투여용 경피 치료 시스템
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
WO2012012417A1 (en) * 2010-07-21 2012-01-26 3M Innovative Properties Company Transdermal adhesive compositions, devices, and methods
SI2468274T1 (sl) 2010-12-14 2015-10-30 Acino Ag Transdermalni terapevtski sistem za dajanje aktivne snovi
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) * 2011-05-13 2012-11-21 에스케이케미칼주식회사 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
US9585862B2 (en) 2011-05-20 2017-03-07 Sk Chemicals Co., Ltd. Patch containing rivastigmine
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
EP2594261A1 (en) 2011-11-18 2013-05-22 Labtec GmbH Composition for transdermal administration of rivastigmine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
EP2859892B1 (en) 2012-06-12 2023-06-07 KM Transderm Ltd. Patch
EP2893927A4 (en) * 2012-09-03 2016-03-09 Nipro Patch Co Ltd SKIN PATCH
KR20140038237A (ko) * 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
US9895320B2 (en) 2012-09-28 2018-02-20 KM Transderm Ltd. Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
CN106413695B (zh) * 2014-04-08 2019-12-10 帝国制药美国公司 利伐斯的明透皮组合物及其使用方法
US10308408B2 (en) 2014-05-15 2019-06-04 Nichiban Co., Ltd. Packaging for adhesive patch containing rivastigmine
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
WO1998030243A1 (en) * 1997-01-08 1998-07-16 Warner-Lambert Company Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
AU5495398A (en) * 1997-01-17 1998-08-07 Takeda Chemical Industries Ltd. Idebenone containing combination agent for treating alzheimer's disease

Also Published As

Publication number Publication date
EP1047409B1 (en) 2002-09-11
KR20010033072A (ko) 2001-04-25
CZ20002557A3 (cs) 2000-10-11
DE69902875D1 (de) 2002-10-17
HU227159B1 (en) 2010-09-28
NO20003472L (no) 2000-08-07
MXPA00006438A (es) 2003-07-21
JP2002500178A (ja) 2002-01-08
CA2315784A1 (en) 1999-07-15
ID27503A (id) 2001-04-12
NZ505650A (en) 2002-10-25
AU745661B2 (en) 2002-03-28
RU2219926C2 (ru) 2003-12-27
HK1034036A1 (en) 2001-10-12
ES2184408T3 (es) 2003-04-01
GB9800526D0 (en) 1998-03-11
KR100569051B1 (ko) 2006-04-10
HUP0004300A3 (en) 2003-05-28
WO1999034782A1 (en) 1999-07-15
NO20003472D0 (no) 2000-07-05
JP3820103B2 (ja) 2006-09-13
CN1288375A (zh) 2001-03-21
PT1047409E (pt) 2002-12-31
DE69902875T2 (de) 2003-05-22
AU2278599A (en) 1999-07-26
SK10532000A3 (sk) 2000-11-07
PL341347A1 (en) 2001-04-09
US6335031B1 (en) 2002-01-01
ATE223711T1 (de) 2002-09-15
IL137100A0 (en) 2001-06-14
SK284622B6 (sk) 2005-08-04
IL137100A (en) 2004-12-15
NO328390B1 (no) 2010-02-08
TR200101021T2 (tr) 2002-06-21
HUP0004300A2 (hu) 2001-05-28
BR9906920A (pt) 2000-10-10
DK1047409T3 (da) 2002-12-30
EP1047409A1 (en) 2000-11-02
CN1129427C (zh) 2003-12-03
CZ300598B6 (cs) 2009-06-24
CA2315784C (en) 2006-06-27
PL201328B1 (pl) 2009-03-31

Similar Documents

Publication Publication Date Title
TR200001688T2 (tr) TTS içeren bir antioksidant.
PT1061900E (pt) Composicoes e metodos para libertacao de uma droga
BR0107869A (pt) Composições farmacêuticas eletrogiradas
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
TR200502189T1 (tr) Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler.
MXPA01007411A (es) Composiciones y metodos para suministro mucoso.
ATE383849T1 (de) Transdermale pharmazeutische zusammensetzung
TW200637529A (en) Topical patch cooling preparation and methods for using the same
TR199802108T2 (tr) Ibandronat içeren oral farmasötik bir formülasyon.
CY1107906T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
HRP20080178T3 (en) Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
TR200400241T4 (tr) Lasofoksifen'in transdermal olarak verilmesi
EP1300143A4 (en) STAMP CONTAINING 4-BIPHENYLACETIC ACID
ATE253374T1 (de) Topische zusammensetzung enthaltend menschlichen epidermalen wachstumsfaktor
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
GEP20094648B (en) Anti-parasiticidal composition
ATE357246T1 (de) Pharmazeutische träger zusammensetzung für produkte auf basis von papain